MOUNT LAUREL, NJ (JANUARY 21, 2008) - The first time Shari Richard put together a video presentation of life in the womb, called Window to the Womb, her powerful presentation brought her before the U.S. Congress. Within months, she was sharing her experience and footage with legislators on Capitol Hill. Richard’s newest video continues her legacy, now utilizing the latest in medical imaging to demonstrate the life of the child in the womb.
Eyewitness 2 – The Next Generation is a sequel to another of Richard’s ground-breaking videos, Eyewitness to the Earliest Days of Life. Eyewitness 2 shows 3D and 4D images from the 1st, 2nd, and 3rd trimester set to music. Fetal development is described using subtitles, making the video ready for use for any language and country.
Catholic PR Wire
Monday, January 21, 2008
Pro-Life Pioneer Announces New Ultrasound DVD
Sunday, January 20, 2008
Women undergoing surgery for ovarian cancer ‘needlessly’ (UK)
Many women are undergoing major surgery unnecessarily because of a lack of ultrasound experts to diagnose ovarian cancer, researchers say.
Improving the quality of preoperative ultrasound examinations could lead to a decrease in the number of operations on women with suspected ovarian cancer, as benign tumours may be discovered before surgery.
Saturday, January 19, 2008
Military Technique Could Aid Stroke Victims
University of Leicester researchers are pioneering use of military radar signal processing methods to help victims of stroke the third most common cause of death in the UK. The Leicester study has discovered that techniques used in radar systems can be modified and have the potential to improve early diagnosis and effective monitoring of stroke victims. Research by Joanne Cowe in the University's Medical Physics group led to the breakthrough which offers huge potential to deliver benefits to patients.
Joanne said: "Stroke is the third most common cause of death and the most common cause of adult disability in the UK and is estimated to cost the NHS over £2.3 billion per year. One quarter of strokes are due to emboli (blood clots or other foreign bodies) blocking small blood vessels in the brain. Emboli can originate from a number of sources such as the heart or from plaques in arteries in the head or neck due to vascular disease.
MedicalNewsToday - complete article
Friday, January 18, 2008
Ultrasound diagnoses idiopathic carpal tunnel better than physical exam
Ultrasound exams of patients with a history of idiopathic carpal tunnel are better diagnostic tools than the standard physical maneuvers known as Tinel's sign and Phalen's maneuver.
Dr. Antonio Naranjo and colleagues in the rheumatology department at the University of Las Palmas de Gran Canaria, Spain, published their study in the November/December 2007 issue of the Journal of Clinical and Experimental Rheumatology. They studied 68 patients with 105 wrists showing symptoms of carpal tunnel syndrome.
Diagnostic Imaging
Tuesday, January 15, 2008
New tool advances injury care
About 100 patients from the Black Hills area have undergone the emerging technology of musculoskeletal ultrasound, a diagnostic ultrasound that is proving to be useful in sports medicine, rheumatology, orthopedics and podiatry.
One of the easiest and most accurate tools for diagnosing soft tissue injuries and pathology, musculoskeletal ultrasound is an accurate, quick, noninvasive and cost-effective method, according to Dr. Steve Wisniew-ski of Rehab Doctors.
source article
Monday, January 14, 2008
Bill would require pre-abortion ultrasound
They could choose not to look, but women seeking an abortion would first have to undergo an ultrasound and review the results with their doctors, under a measure proposed last week in the General Assembly.
The measure by Sen. Jack Westwood, a Northern Kentucky legislator who opposes abortion, would require doctors to perform ultrasounds on women seeking abortions and allow women to see the images before terminating their pregnancies.
Physicians who don't comply could be fined up to $100,000 for the first offense and $250,000 for each subsequent offense.
source article
Thursday, January 10, 2008
Fetus Size Adversely Affected By Pollution
Exposure to air pollution significantly reduces foetus size during pregnancy, according to a new study by Brisbane scientists.
Queensland University of Technology senior research fellow Dr Adrian Barnett said the study compared the foetus sizes of more than 15,000 ultrasound scans in Brisbane to air pollution levels within a 14km radius of the city.
"The study found that mothers with a higher exposure to air pollution had foetuses that were, on average, smaller in terms of abdominal circumference, head circumference and femur length," Dr Barnett said.
source
Tuesday, January 8, 2008
View Of Liver Tumors Sharpened By High-Energy Ultrasound
A high-energy form of ultrasound imaging developed by researchers at Duke University's Pratt School of Engineering produces pictures of liver tumors that are better than those made with traditional ultrasound, according to results of a clinical study.
The study suggests that the imaging method known as Acoustic Radiation Force Impulse (ARFI) ultrasound might offer a new tool for screening patients at increased risk for liver cancers, according to the researchers. They say it might also play a useful role in guiding biopsy procedures and minimally invasive therapies aimed at destroying cancerous tissues found deep in the abdomen.
MedicalNewsToday
Monday, January 7, 2008
Three-D sonography used to detect bladder tumors proves promising
Three-D ultrasound examination shows the location, size, and perivesical spreading of bladder tumors just as well as conventional cystoscopy. The technique has the advantage of being noninvasive.
Bladder cancer is the fourth most common cancer in men in the U.S. and the 10th most common in women. It usually occurs in patients over 68 years of age, so a noninvasive way to evaluate cases in elderly patients could lower risks of complications.
Diagnostic Imaging
Friday, January 4, 2008
Escalon(R) Announces FDA 510(k) Clearance For Sonomed MASTER-VU(TM) B-Scan System
Escalon Medical Corp. (Nasdaq Capital Market: ESMC) announced that its Sonomed, Inc. subsidiary received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the MASTER-VU(TM) ophthalmic B scan ultrasound system. The MASTER-VU(TM) System consists of a B scan probe that can be interfaced to a standard personal computer (via a USB cable connection) using Sonomed's proprietary software, thereby converting the personal computer into an ophthalmic ultrasound system. Sonomed plans to commence shipments of the product in the United States immediately.
Barry Durante, Sonomed's President stated: "The FDA clearance, along with the previously received CE certification, will allow Sonomed to market this new breakthrough instrumentation worldwide. With computers becoming standard in most ophthalmic physician offices, purchasing the probe and software offers complete portability for use in multiple locations. Loading the software in computers in multiple offices allows the physician to carry only the probe from office to office. We expect that the MASTER-VU(TM) will be a valuable addition to our product line in both the U.S. and international marketplace."
MedicalNewsToday
Friday, December 28, 2007
Ultrasound fails to spot ovarian cancer
Annual screening with a technique called transvaginal ultrasound, coupled with a blood test for CA125, a protein that can be elevated in the setting of ovarian cancer, does not reliably detect ovarian cancer early, at a more curable stage, according to a new study.
"We and other groups confirm that the current method of ovarian screening, which is a combination of ultrasound scans and (blood) markers, is ineffective," Dr Emma R Woodward from Birmingham Women's Hospital, UK, told Reuters Health.
"Therefore, for women at high risk of developing ovarian cancer, the only real option at present to prevent ovarian cancer death is to have the ovaries removed as a preventive measure."
source
SonoSite Begins Customer Shipments Of S Series Point-Of-Care Ultrasound Tools
SonoSite, Inc. (Nasdaq:SONO), the world leader in point-of-care, hand-carried ultrasound, announced that it has begun worldwide shipments of its S Series ultrasound tools. Based on the company's fourth generation technology platform, the S Series product line combines the processing power, image quality and advanced data management features of SonoSite's newly introduced M-Turbo™ system with a customized user interface to address the specific needs of four clinical specialties.
"SonoSite is the only company that has designed a system that can withstand rigorous use in the Intensive Care Unit (ICU)," said John M. Oropello, MD, FCCP, FCCM, Professor of Surgery and Medicine, Program Director, Critical Care Medicine and Co-Director, Neurosurgical - ICU, Mount Sinai School of Medicine, New York. "We evaluated a lot of machines and no one else has taken into account what critical care physicians need. Both the S-ICU and M-Turbo have superb image quality and are easy to clean-so essential to infection control. I can foresee the day when there will be an S ultrasound tool mounted by every bedside in the ICU."
source
Saturday, December 22, 2007
ZONARE Ranked Best in KLAS as Hand Carried Ultrasound Vendor in 2007 Top20
MOUNTAIN VIEW, Calif., Dec. 20 /PRNewswire/ -- ZONARE Medical Systems, a developer of premium ultrasound systems, today announced it has been ranked Best in KLAS as the top hand carried ultrasound (HCU) vendor in the KLAS Top20: Year-End Report published this week. Previously, the company was ranked number one in the inaugural HCU KLAS study. KLAS, a highly respected research firm specializing in monitoring and reporting the performance of information technology and medical imaging vendors in the healthcare field, continued several studies to incorporate additional customer data in order to determine Best in KLAS for 20 different categories for the year, including the HCU market.
press release
Monday, December 10, 2007
GE Healthcare Licenses Rights To Ultrasound Diagnostic Protocol Developed By Eastern Virginia Medical School Obstetrician
GE Healthcare, a leading manufacturer of 3D/4D ultrasound systems, has licensed a technique patented by an Eastern Virginia Medical School (EVMS) obstetrician that can automate the acquisition of ultrasound images used by physicians to diagnose fetal heart defects. GE Healthcare has licensed the software for exclusive use in its 3D/4D ultrasound systems.
Alfred Abuhamad, M.D., chairman of obstetrics and gynecology at EVMS - recognized worldwide for his skills in using ultrasound to detect fetal heart defects - developed the automation protocol, called Sonography based Volume Computer Aided Diagnosis (SonoVCAD).
source
Friday, December 7, 2007
Toshiba And TomTec Deliver New Tools For Cardiac 4D Ultrasound
Toshiba Medical Systems Corporation and TomTec Imaging Systems GmbH announced an agreement to deliver new tools for assessing cardiac 4D data and a collaboration to make them more widely available at EuroEcho which is held from December 5th to 8th in Lisbon, Portugal. With the recent announcement of Toshiba's ArtidaTM Cardiac 4D Ultrasound System, a variety of new 4D capabilities were released. TomTec diagnostic workstations will be able to read Artida's data providing increased customer options for image review and a host of new advanced applications.
"We designed Artida to be the first of a new generation of the cardiac 4D ultrasound systems." said Hiroyuki Tsujino, General Manager, Ultrasound Systems Division at Toshiba Medical Systems Corporation. "This is why we developed the smallest and lightest 4D transducers together with the SmartCore technology to generate precise 4D images quickly. To provide a total workflow solution to the customer, TomTec was a natural choice for the image review and analysis. We admire TomTec for its long-standing commitment to innovation in diagnostic ultrasound"
source
Tuesday, December 4, 2007
New Research Reveals Ultrasound Treatment Of Benefit To Prostate Cancer Sufferers
First analysis of the long-term results with transrectal HIFU in patients with localized prostate cancer (European Journal of Urology online).
Prostate cancer experts say high intensity focussed ultrasound (HIFU) is an effective treatment option for men with prostate cancer, according to new research published this month in the European Journal of Urology online.
Experts from France and Germany studied the results of 140 people with prostate cancer over an eight year period and published their findings in the EJU.
source